The coding of minimally invasive endoscopic treatments is now available

Olympus supports the recent creation of new reimbursement billing codes for Peroral Endoscopic Myotomy (POEM) and Endoscopic Submucosal Dissection (ESD) procedures; Decision expected to improve patient access to minimally invasive procedure

CENTRAL VALLEY, Pennsylvania., April 18, 2022 /PRNewswire/ — Olympus, a global technology leader in designing and delivering innovative solutions for medical and surgical procedures, today announced support for new reimbursement from the Centers for Medicare and Medicaid Services that is expected to improve the patient access to endoscopic submucosal dissection (ESD) and for peroral endoscopic myotomy (POEM). Both are minimally invasive procedures performed endoluminally as an alternative to open or laparoscopic surgery.

  • Efficient January 1, 2022a new level 1 CPT code is available for 43497transoral lower esophageal myotomy, i.e. peroral endoscopic myotomy (POEM).1
  • Moreover, effective October 1, 2021there is a new HCPCS code C9779endoscopic submucosal dissection (ESD), including endoscopy or colonoscopy, mucosal closure, if applicable.2

The issuance and availability of these POEM and ESD reimbursement billing codes will provide providers with a pathway to reimbursement, which should increase patient access. POEM is an alternative to laparoscopic Heller myotomy for the treatment of achalasia or non-relaxing lower esophageal sphincter. ESD is an established and effective treatment for lesions of the gastrointestinal tract, including cancerous and precancerous tumors. Compared to endoscopic mucosal resection (EMR), ESD allows complete en bloc removal rather than fragmentary resection of large tumors larger than 2 cm. The procedure offers a higher rate of complete tumor removal, reducing the need for laparoscopic surgery and the associated risks.3

“The decision to establish coding will lead to reimbursement and coverage for these procedures and will mean that patients will now have a better chance of having a better quality of life,” says Dr. Norio Fukamigastroenterologist at the Mayo Clinic in Arizona. “These rulings also have the potential to educate patients and healthcare professionals about the treatment options available. Additionally, issuing these billing codes for these procedures is a first step in creating a consistent payment process. for the procedure and the responsibility of the doctors for the quality procedures.”

“Olympus is a pioneer in endoscopic endoluminal procedures. Beginning with our work with physicians in Japan more than 20 years ago to develop endoscopic knives that enabled the introduction of ESD, we are committed to expanding access to this minimally invasive procedure,” said Kurt Heinegroup vice president of the endoscopy division at Olympus Corp. “Through our partnership with GI Companies, we have advocated for positive change while striving to provide best-in-class training and a broad portfolio of devices to meet every procedural application.”

Visit the Olympus product page to learn more about the full line of gastroenterology equipment.

About Olympus
For more than 100 years, Olympus has been committed to making people’s lives healthier, safer and more fulfilling. In its Endoscopic Solutions business, Olympus uses innovative capabilities in medical technology, therapeutic intervention and precision manufacturing to help healthcare professionals deliver diagnostic, therapeutic and minimally invasive procedures to improve clinical outcomes. , reduce overall costs and improve patient quality of life and safety. . Beginning with the world’s first gastrocamera in 1950, Olympus’ endoscopic solutions portfolio has grown to include endoscopes, laparoscopes and video imaging systems, as well as systems integration solutions and services. medical. For more information, visit medical.olympusamerica.com.

dr. Norio Fukami is a consultant for Olympus Corporation, its subsidiaries and/or affiliates.

1 CPT & Description: Copyright 2021 American Medical Association. All rights reserved. Applicable FARS/DFARS apply to government use
2 Centers for Medicare and Medicaid Services, “October 2021 Update of the Hospital Outpatient Prospective Payment System” September 16, 2021. https://www.cms.gov/files/document/R10997CP.pdf#page=21
3 Draganov PV, Wang AY, Othman MO, Fukami N. “AGA Institute Clinical Practice Update: Submucosal Endoscopic Dissection in the United States.” Clin Gastroenterol Hepatol. 2019 Jan 17. (1):16-25.e1. doi: 10.1016/j.cgh.2018.07.041. Published online August 2, 2018. Accessed October 18, 2021

SOURCEOlympus

Comments are closed.